CGNX:NGS-Cognex Corporation (USD)

EQUITY | Scientific & Technical Instruments | Nasdaq Global Select

Last Closing

USD 42.19

Change

-0.67 (-1.56)%

Market Cap

USD 5.21B

Volume

0.67M

Analyst Target

USD 58.73
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cognex Corp is a provider of machine vision products that capture and analyze visual information in order to automate tasks, mainly in manufacturing processes, where vision is required.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
TRMB Trimble Inc

-0.20 (-0.27%)

USD 14.95B
MKSI MKS Instruments Inc

-0.97 (-0.86%)

USD 6.77B
NOVT Novanta Inc

-4.54 (-2.60%)

USD 6.26B
ITRI Itron Inc

-1.96 (-1.62%)

USD 5.04B
MLAB Mesa Laboratories Inc

-4.63 (-4.12%)

USD 0.62B
ITRN Ituran Location and Control Lt..

-0.04 (-0.14%)

USD 0.53B
FARO FARO Technologies Inc

-0.86 (-3.11%)

USD 0.34B
MVIS Microvision Inc

-0.04 (-4.04%)

USD 0.23B
SOTK Sono-Tek Corp

+0.15 (+3.45%)

USD 0.07B
LUNA Luna Innovations Incorporated

+0.04 (+2.52%)

USD 0.06B

ETFs Containing CGNX

MAKX ProShares S&P Kensho Smar.. 5.24 % 0.00 %

+0.24 (+-0.30%)

USD 0.94M
LADR:XETRA L&G Optical Technology & .. 4.14 % 0.00 %

-0.08 (-0.30%)

N/A
BOTZ:SW Global X Robotics & Artif.. 3.77 % 0.00 %

-0.06 (-0.30%)

N/A
BOTG:LSE Global X Robotics & Artif.. 3.15 % 0.00 %

-0.06 (-0.30%)

USD 0.01B
BOTZ:LSE Global X Robotics & Artif.. 3.15 % 0.00 %

+0.04 (+-0.30%)

USD 0.06B
BOTZ Global X Robotics & Artif.. 0.00 % 0.70 %

-0.34 (-0.30%)

USD 2.59B
IRBO 0.00 % 0.47 %

N/A

N/A
RBOT:CA Global X Robotics & AI In.. 0.00 % 0.86 %

-0.35 (-0.30%)

CAD 0.06B
SMD 0.00 % 0.10 %

N/A

N/A
XMC:CA iShares S&P US Mid-Cap 0.00 % 0.16 %

-0.04 (-0.30%)

CAD 0.39B
XMH:CA iShares S&P US Mid-Cap CA.. 0.00 % 0.16 %

-0.14 (-0.30%)

CAD 0.26B
XTH 0.00 % 0.35 %

N/A

N/A
IS3V:XETRA iShares Global Inflation .. 0.00 % 0.00 %

-0.02 (-0.30%)

USD 0.20B
IJH:AU iShares CoreS&P MidCap 40.. 0.00 % 0.00 %

-0.41 (-0.30%)

USD 0.32B
RBTZ:AU BetaShares Global Robotic.. 0.00 % 0.00 %

-0.25 (-0.30%)

USD 0.27B
XMC-U:CA iShares S&P U.S. Mid-Cap .. 0.00 % 0.00 %

+0.07 (+-0.30%)

N/A
SPRX Spear Alpha ETF 0.00 % 0.00 %

-0.06 (-0.30%)

N/A
XB0T:XETRA Global X Robotics & Artif.. 0.00 % 0.00 %

+0.01 (+-0.30%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.08% 55% F 48% F
Dividend Return 0.54% 50% F 9% A-
Total Return 1.62% 55% F 45% F
Trailing 12 Months  
Capital Gain 14.77% 68% D+ 58% F
Dividend Return 0.82% 50% F 10% F
Total Return 15.59% 68% D+ 56% F
Trailing 5 Years  
Capital Gain -17.05% 47% F 38% F
Dividend Return 6.38% 75% C 18% F
Total Return -10.67% 47% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain -4.51% 41% F 28% F
Dividend Return -3.22% 41% F 28% F
Total Return 1.29% 75% C 33% F
Risk Return Profile  
Volatility (Standard Deviation) 38.11% 82% B 49% F
Risk Adjusted Return -8.44% 32% F 30% F
Market Capitalization 5.21B 95% A 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Scientific & Technical Instruments) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 39.60 31% 14%
Price/Book Ratio 4.40 26% 27%
Price / Cash Flow Ratio 61.38 16% 5%
Price/Free Cash Flow Ratio 53.09 16% 6%
Management Effectiveness  
Return on Equity 5.83% 71% 68%
Return on Invested Capital 7.38% 86% 72%
Return on Assets 2.91% 67% 78%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector